MetaCap

Achieve Life Sciences Financial Ratios

NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

5.56-0.31 (-5.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Achieve Life Sciences ratio analysis

Return on equity reached -254.0%, meaning Achieve Life Sciences generated -2.54 dollars of profit for every dollar of shareholders' equity. Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.

Summary generated from market data by MetaCap's automated system. Methodology

Achieve Life Sciences financial ratios (annual)

Achieve Life Sciences annual financial ratios
RatioFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Return on equity (ROE)-254.0%-190.6%—-510.1%-118.2%-39.5%-90.8%-80.3%-67.0%-202.3%
Return on assets (ROA)-130.8%-103.1%-153.9%-141.3%-69.8%-36.6%-77.8%-66.5%-107.0%-32.4%
Current ratio4.395.460.821.279.8012.606.044.752.930.01

Related